MedPath

A study on the effect of proton pump inhibitors on intra-gastric pH in healthy adults: comparison of rabeprazole and esomeprazole

Not Applicable
Conditions
Gastroesophageal reflux diseases (GERD)
Registration Number
JPRN-UMIN000013165
Lead Sponsor
Shimane University Faculty of Medicine, Department of Internal Medicine II
Brief Summary

There were no statistically significant difference regarding primary outcome between Rabeprazole and Esomeprazole. No adverse events were reported in all enrolled subjects.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
10
Inclusion Criteria

Not provided

Exclusion Criteria

1. subjects with taking drugs affecting gastrointestinal motor function 2. subjects with upper abdominal symptom 3. subjects with a history gastrectomy 4. subjects who cannot stop smoking during the study period 5. subjects who are not eligible for participation judged by a doctor

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath